(3R)-3-CYCLOPENTYL-3-(4-(2-HYDROXY-6-OXO-2,3,5,7-TETRAHYDROPYRROLO(2,3-D)PYRIMIDIN-4-YL)PYRAZOL-1-YL)PROPANENITRILE
UNII Q2NX38BMM6
Substance Identification & Data
This profile provides standardized clinical and technical data for (3r)-3-cyclopentyl-3-(4-(2-hydroxy-6-oxo-2,3,5,7-tetrahydropyrrolo(2,3-d)pyrimidin-4-yl)pyrazol-1-yl)propanenitrile, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Q2NX38BMM6.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C17H20N6O2 LAYBKCQPGSEBPV-FWJOYPJLSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (3r)-3-cyclopentyl-3-(4-(2-hydroxy-6-oxo-2,3,5,7-tetrahydropyrrolo(2,3-d)pyrimidin-4-yl)pyrazol-1-yl)propanenitrile. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.